Latest Breaking News On - Advisory business services - Page 5 : comparemela.com

Savant Wealth Management Steps Back into Acquisition Mode

Savant Wealth Management Steps Back into Acquisition Mode
wealthmanagement.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wealthmanagement.com Daily Mail and Mail on Sunday newspapers.

Salt lake cityUnited statesBloomfield hillsRebecca stroudBrent brodeskiWayne titusRamey beckerChris carlsonMelissa orlandoCynosure groupAdvisory business servicesSavant wealth managementBusiness advisory servicesHuber financial advisorsNonami investmentsVlassic investments

Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession

Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of texasEddie varnadoErick hawkinsEddiel varnadoLori lawleyCarl langrenLisa millerLumos pharmaUniversity of north carolinaKenan flagler school of businessWuxi clinical developmentCompany annual report on formCompany onMartin mariettaAdvisory business services at ernst young

Baudax Bio Strengthens Management Team with Appointment of Richard S Casten as Chief Financial Officer

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer Company Also Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) March 08, 2021 07:00 ET | Source: Baudax Bio, Inc. Baudax Bio, Inc. Malvern, Pennsylvania, UNITED STATES MALVERN Pa., March 08, 2021 (GLOBE NEWSWIRE) Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the appointment of Richard S. Casten, CPA, MBA as Chief Financial Officer. In this role, Mr. Casten will be responsible for leading and directing the financial activities of the Company. Mr. Casten brings to Baudax 25 years of diversified financial experience across pharmaceutical, Fortune 500 consumer products and public accounting. He replaces Ryan D. Lake, CPA who is transitioning to full time Chief Financial Officer for Recro.

Lehigh universityUnited statesJohnson schoolDavid rosenSam martin claudia styslingerBaudax bioRichards castenGerri henwoodFishbein companyLupin pharmaceuticals incJohnson school at cornell universityAlkermes pharma ireland limitedMaster in business administrationBaudax bio incExchange commissionPennsylvania institute of certified public accountants